Veterinary and Comparative Orthopaedics and Traumatology, Table of Contents Vet Comp Orthop Traumatol 2013; 26(06): VII-VIIIDOI: 10.3415/VCOT-13-10-0125 Guest Editorial Schattauer GmbH Out-Sourcing Stem Cells for Clinical Applications Recommend Article Abstract Buy Article Full Text References References 1 Pigott JH, Ishihara A, Wellman ML. et al. Inflammatory effects of autologous, genetically modified autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses. Vet Comp Orthop Traumatol 2013; 26: 453-460. 2 Gafni Y, Turgeman G, Liebergal M. et al. Stem cells as vehicles for orthopedic gene therapy. Gene Ther 2004; 11: 417-426. 3 Grande DA, Mason J, Light E. et al. Stem cells as platforms for delivery of genes to enhance cartilage repair. J Bone Joint Surg Am 2003; 85 (Suppl 2) 111-116. 4 Park J, Gelse K, Frank S. et al. Transgene-activated mesenchymal stem cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/ periosteum- and fat-derived cells. J Gene Med 2006; 8: 112-125. 5 Agung M, Ochi M, Yanada S. et al. Mobilization of bone marrow-derived mesenchymal stem cells into the injured tissues after intraarticular injection and their contribution to tissue regeneration. Knee Surg Sports Traumatol Arthrosc 2006; 14: 1307-1314. 6 Jing XH, Yang L, Duan XJ. et al. In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection. Joint Bone Spine 2008; 75: 432-438. 7 Murphy JM, Fink DJ, Hunziker EB. et al. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003; 48: 3464-3474. 8 Watts AE, Nixon AJ. Distribution and homing of stem cells after intra-articular injection to normal and arthritic joints. Proceedings of the 2011 ACVS Veterinary Symposium. 2011. November 3-5 Chicago, IL, USA: 40 E50. 9 González MA, González-Rey E, Rico L. et al. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 2009; 60: 1006-1019. 10 Zheng ZH, Li XY, Ding J. et al. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Rheumatology 2008; 47: 22-30. 11 Augello A, Tasso R, Negrini SM. et al. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 2007; 56: 1175-1186. 12 Lozito TP, Tuan RS. Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J Cell Physiol 2011; 226: 385-396. 13 Toghraie FS, Chenari N, Gholipour MA. et al. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in rabbit. Knee 2011; 18: 71-75. 14 Grigolo B, Lisignoli G, Desando G. et al. Osteoarthritis treated with mesenchymal stem cells on hyaluronan-based scaffold in rabbit. Tissue Eng Part C Methods 2009; 15: 647-658. 15 Frisbie DD, Kisiday JD, Kawcak CE. et al. Evaluation of adipose derived stromal vascular fraction or bone marrow derived mesenchymal stem cells for treatment of osteoarthritis. J Orthop Res 2009; 27: 1675-1680. 16 McIlwraith CW, Frisbie DD, Rodkey WG. et al. Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects. Arthroscopy 2011; 27: 1152-1161. 17 Ferris DJ, Frisbie DD, Kisiday JD. et al. Clinical follow-up of horses treated with bone marrow derived mesenchymal stem cells for musculoskeletal lesions. Proceedings of the 55th Annual Convention of the American Association of Equine Practitioners. 2009. December 5-9 Las Vegas, Nevada, USA: 55 59-60. 18 Walmsley JP, Phillips TJ, Townsend HG. Meniscal tears in horses: an evaluation of clinical signs and arthroscopic treatment of 80 cases. Equine Vet J 2003; 35: 402-406. 19 Cohen JM, Richardson DW, McKnight AL. et al. Long-term outcome in 44 horses with stifle lameness after arthroscopic exploration and debridement. Vet Surg 2009; 38: 543-551. 20 Murphy MJ, Dixon K, Beck S. et al. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum 2002; 46: 704-713. 21 Kiefer K, Conzemius MG, Pluhar GE. Canine adipose derived stem cell viability following exposure to synovial fluid from osteoarthritic joints. Vet Comp Orthop Traumatol. 2013 26. A7.